About Novavax Inc
Novavax is an American healthcare company that focuses on the creation and development of vaccines. It has offices in the US and Sweden. Novavax is a prominent company within the biotechnology industry, after completing many vaccine trials for illnesses such as Ebola, RSV and influenza. In particular, Novavax stock gained prominence during the Covid-19 pandemic, as it was one of the main contenders for an approved vaccination. The company is listed on the NASDAQ stock exchange and is also a constituent of the Russell 2000 stock index, which measures small-cap companies. View our holding costs, margin rates and trading hours below to start spread betting or trading CFDs on Novavax’s share price.
Why trade Novavax Inc with CMC Markets?
We've invested over £100m into our trading platform, creating pioneering technology that puts professional-grade grade software in your hands.
Set your default position size and enter with a single 'click'.
99.9% fill rate with 0.0029s execution*
Wherever possible we fill your trade and always at the price you see.
99.95%+ platform stability**
We consistently achieve core platform uptime, allowing you to focus on your trading.
We crunch 225m prices every day, from up to 14 feeds from tier one liquidity providers.